Blog Archives

EHRs Deliver the Goods, or at Least the Quality

There have been a number of research studies published that question the value of Electronic Health Records (EHRs), particularly as it pertains to improving quality of care and ultimately outcomes. Chilmark has always viewed these reports with a certain amount

Share

Trends in Patient Engagement

As part of the process of setting our broader research agenda at Chilmark Research, we do a significant amount of secondary research combined with more limited, but highly focused primary research. We use this research to identify the “white spaces”

Share

HIE Market Snippets

In January, we released our HIE Market Report: Analysis & Trends which was extremely well-received. Sales have exceeded our rather optimistic projections – great for us. But what we are most proud of and honestly what keeps us going is

Share

Looking at Healthcare Through Payer Lenses: Part Two

Payers, as with the rest of the healthcare industry, have a lot on their plate right now. Healthcare reform, via the Affordable Care Act (ACA) continues its march forward despite legal and political uncertainty. Struggling to define the payer role

Share

Looking at Healthcare Through Payer Lenses: Part One

Attending the annual health insurers confab (AHIP Institute) last week gave one some insight as to the challenges this part of the healthcare industry is facing. There were plenty of sessions on addressing data analytics for everything from population health

Share

Likely Suitors as Thomson Reuters Exits Healthcare

Earlier this week, Thomson Reuters (TR) announced that it intends to sell off its healthcare unit. A logical first response is: What they heck, why would they sell right now when the healthcare market is so hot and shows no signs

Share

Matches Made in Philly

Last week an amazing event occurred. Ten young innovative companies that were chosen from nearly 30 applicants had the opportunity to sit down and make their pitch to 10 of the largest healthcare organizations in the northeast region. Through speed

Share

Rational Thought Infects HITECH

Couple of weeks back the HIT Policy Committee began to seriously consider what a delay of Stage Two meaningful use (MU) might look like. This push for a delay is being driven in large part by EHR vendors. The problem

Share

Musings on PHRs & Consumer Engagement

The recent post on Google Health going into the deep freeze has solicited a number of emails, including some from the press. In one of those emails a reporter had spoken to several industry thought leaders to garner their opinions

Share

Microsoft HSG Bets Future on Amalga

Microsoft’s Health Solutions Group (HSG), which has straddled the fence with consumer-facing (HealthVault) and corporate-facing (Amalga), is increasingly moving to the corporate side of the fence. Not that surprising considering that the consumer market continues to struggle (Google Health is

Share

Windy City, Turbulent Times

Special Note: When this post first went up an image of a tornado was used as a metaphor for the very turbulent times that the healthcare sector is currently experiencing. Little did we know that this week would see the

Share

Fostering Innovation in Healthcare IT

As in most sectors, innovation in healthcare IT (HIT) is by and large incremental. A tweak here and added feature there to some existing application, e.g., what we are seeing today from EHR vendors as they strive to meet meaningful

Share

Robust Processes Supported by Health IT Core to ACO Success

On March 31st, the HHS’s Center for Medicare and Medicaid Services (CMS) dropped its neutron bomb (proposed Accountable Care Organization (ACO) rules, caution PDF) on the healthcare industry. Much like the neutron bomb, the proposed rules will leave buildings standing,

Share

Much Ado About Patient Portals

From Chilmark Research’s perspective, patient portals are by and large Much Ado About Nothing. Sure, plenty of healthcare organizations (HCO) talk about patient access, engagement, and satisfaction and how they wish to empower their patients. They point to their glossy

Share

HIMSS11 Shrinking the World Down One Size

  Like Dilbert, I left HIMSS11 with a sense of scale that was somewhat skewed. The first time I crossed the pedestrian bridge overlooking the vendor showroom, I was immediately struck by the vastness of it all.  The showroom itself

Share

HIMSS’11: Setting Expectations

Over a 1,000 exhibitors, some 30,000+ attendees and I come away from HIMSS, again, thinking is this all there is? Where is the innovation that the Obama administration i.e., Sec. Sebellius and Dr. Blumenthal both touted in their less than

Share

2011 Predictions: MU Goes Tactical, ACO Strategic

In the Healthcare IT (HIT) market, 2010 was the year of meaningful use (MU). Healthcare organizations (HCOs) of all sizes developed plans, began making IT modifications and began adopting the technology they needed to meet Stage One MU requirements and

Share

Snippet from Forthcoming HIE Report

OK, I admit it, I have been negligent. Since that brief holiday greetings post a couple of weeks back, I have not written a single thing for this site. Even before that post, my writing, or at least frequency thereof,

Share

Analysis: Aetna Jumps into HIE Market Acquiring Medicity

First it was United Health Group’s (UHG) Ingenix Division’s acquisition of leading HIE vendor (and top competitor to Medicity) Axolotl. Then this morning Aetna counters by acquiring Medicity. In just a few short months these two payers have completely changed

Share

Smashing Myths & Assumptions: PHR for Urban Diabetes Care

There remains an unhealthy level of skepticism in the market as to whether or not consumers will use a personal health record (PHR). While a certain level of skepticism is healthy in any market, the level to which it is

Share

Who We Are

Chilmark Research is the only industry analyst firm focusing solely on health IT. We combine proven research methodologies with intelligence and insight to provide cogent analyses of the emerging technologies that have the greatest potential to improve healthcare. We do not shy away from making tough calls, and are respected in the industry for our direct and thoughtful commentary.